MEDVi vs Found: Which GLP-1 Program Is the Right Fit in 2026?
By the Weight Loss Provider Guide editorial team — an independent comparison resource for GLP-1 telehealth providers. Pricing and policies refreshed monthly.
Last updated: • Last verified: • Next re-verification: June 5, 2026
The bottom line
- MEDVi wins for cash-pay shoppers who want the simplest path: $179 the first month, $299 ongoing, no contract, medication included on the compounded plan.
- Found wins if you have insurance, want a coach plus an app community, or want a wider menu of medications — including non-GLP-1 options.
- Both are real telehealth platforms that connect you with licensed clinicians who can prescribe GLP-1 medications. They take very different paths to get you there.
Still unsure? Take our 60-second GLP-1 matching quiz →
At a glance: MEDVi vs Found in one screen
Answer capsule: MEDVi is a cash-pay GLP-1 telehealth platform that starts at $179 the first month with no contract on the compounded plan and includes the medication in the price. Found is a telehealth program that says it accepts most major insurance, includes coaching plus an app, and offers more than 10 medication options — though the lowest advertised prices require 12-month upfront prepayment, and branded GLP-1 medication is billed separately.
| Quick check | MEDVi | Found |
|---|---|---|
| Best for | Cash-pay, simplest start | Insurance, coaching, broader medication menu |
| Starting price | $179 (first month, compounded sema injection) | $149/mo with insurance OR $199/mo cash-pay (12-mo prepaid plans) |
| Monthly without prepay commitment | $299/mo (compounded sema) | $199/mo with insurance / $299/mo cash-pay |
| Insurance | Cash-pay only | Says it accepts most major insurance |
| Medication included? | Yes (compounded plan) | Compounded plan: yes. Branded plan: medication billed separately |
| Brand-name access | Wegovy® pill, Wegovy® injection, Zepbound® injection ($99 + medication cost) | Wegovy®, Ozempic®, Zepbound®, Mounjaro®, Foundayo™, Saxenda® (medication billed separately) |
| Coaching / community | Provider messaging and 24/7 support | Coach + app + AI assistant + member community |
| Cancellation | Anytime; ≥72 hours before billing | Anytime on monthly plans; multi-month prepaid plans pay through term |
| State availability | Verify in checkout (most states) | Insurance plans in 40+ states; California shows “no plans available” |
| FDA warning letter on file | Yes — #721455, Feb 20, 2026 (marketing language) | None on file as of May 5, 2026 |
The rest of this page goes deeper on each of these so you can pick with confidence.

What we actually verified before publishing
Answer capsule: We checked every price, every policy, and every regulatory claim on this page directly from MEDVi’s pricing page, Found’s pricing page and offer terms, the FDA warning letters database, and current third-party review sources on May 5, 2026. We re-verify pricing and policy claims monthly.
Most “MEDVi vs Found” pages quote prices that were true 6 months ago and skip the regulatory context entirely. We did the homework so you don’t have to:
- MEDVi compounded semaglutide pricing — confirmed live at glp.medvi.org: GLP-1 injections from $179 first month, refills locked at $299
- MEDVi brand-name additions — Wegovy® pill, Wegovy® injection, and Zepbound® injection listed at “$99 membership + medication cost” on the MEDVi product page
- MEDVi pharmacy partners — publicly named on home.medvi.org: Triad Rx, RedRock Pharmacy (St. George, UT), and Beaker Pharmacy & Compounding (McKinney, TX)
- MEDVi cancellation language — confirmed: cancel at least 72 hours before billing; full refund if medically disqualified; no refund on ordinary cancellation
- Found pricing tiers — confirmed live at joinfound.com/plans-and-pricing: from $149/mo (insurance, 12-mo prepaid) or $199/mo (cash, 12-mo prepaid); monthly plans $199–$299
- Found brand-name medication-only prices — confirmed: Ozempic® ~$1,100/mo, Wegovy® from $650/mo, Zepbound® from $650/mo, Mounjaro® ~$1,100/mo
- Found offer terms — confirmed at joinfound.com/terms/offer-terms-v3: compounded medication included on both plans; branded GLP-1 billed separately; refund within 3 days of signup OR before first medical consultation
- Found state availability — verified on pricing widget: 40+ states show in-network plans; California shows “No plans available for this state”
- FDA warning letter to MEDVi #721455 dated Feb 20, 2026 — read directly from the FDA warning letters database
- Trustpilot and ConsumerAffairs review counts — captured at the time of verification; volume changes daily
How much does MEDVi or Found really cost in 2026?
Answer capsule: MEDVi’s compounded semaglutide costs $179 the first month and $299 every month after, with medication included and no contract. Found’s GLP-1 program starts at $149/month with insurance or $199/month cash-pay only when you prepay 12 months upfront — monthly plans cost $199 (insurance) or $299 (cash-pay) and branded GLP-1 medications are billed separately on top.
The headline prices on both sites are technically true. They’re also a little misleading. Here’s what each one actually costs over a full year.
MEDVi cost: what you’ll actually pay
| What you get | First month | Ongoing months | Notes |
|---|---|---|---|
| Compounded semaglutide injection | $179 | $299/mo | Most popular plan. Medication included. No contract. |
| Compounded semaglutide tablet | $249 | Verify at checkout | Oral option for needle-averse readers |
| Wegovy® pill (FDA-approved) | $99 + medication cost | $99 + medication cost | Newer addition. Cost of medication is separate. |
| Wegovy® injection (FDA-approved) | $99 + medication cost | Same | Subject to availability |
| Zepbound® injection (FDA-approved) | $99 + medication cost | Same | Subject to availability |
Found cost: what you’ll actually pay
Found’s pricing has more moving parts. There are four price points to know, all confirmed on Found’s pricing page:
| Plan type | Price | What’s included | Catch |
|---|---|---|---|
| GLP-1 program with insurance, 12-mo prepaid | $149/mo | Clinician care + compounded medication | You pay 12 months upfront; copays may apply |
| GLP-1 program cash-pay, 12-mo prepaid | $199/mo | Clinician care + compounded medication | You pay 12 months upfront |
| Monthly plan, with insurance | $199/mo | Clinician care + compounded medication | Pay as you go; copays may apply |
| Monthly plan, cash-pay | $299/mo | Clinician care + compounded medication | Pay as you go |
If you want brand-name medication through Found (like Wegovy® or Zepbound®), the medication is billed separately on top of your membership. Found lists Wegovy® from $650/mo, Zepbound® from $650/mo, Ozempic® around $1,100/mo, and Mounjaro® around $1,100/mo for medication-only cash-pay.
12-month totals on Found, by realistic scenario:
| Scenario | Math | 12-month total |
|---|---|---|
| Cash-pay monthly compounded plan | 12 × $299 | $3,588 |
| Cash-pay 12-mo prepaid compounded plan | 12 × $199 | $2,388 (paid upfront) |
| Insurance monthly compounded plan | 12 × $199 + copays | $2,388 + copays |
| Insurance 12-mo prepaid compounded plan | 12 × $149 + copays | $1,788 + copays (paid upfront) |
| Branded Wegovy® cash-pay | Plan price + ~$650 medication × 12 | Plan price plus ~$7,800 in medication cost |
So who’s actually cheaper?
MEDVi is cheaper if:
- • You’re paying cash and you want to start small
- • You don’t want to commit 12 months upfront
- • You want compounded semaglutide (cheapest starting point on this page)
Found is cheaper if:
- • Your insurance covers GLP-1s
- • You’re willing to prepay 12 months for the lowest rate
- • You’d otherwise pay full retail for brand-name Wegovy® or Zepbound®
What medications can you actually get prescribed?
Answer capsule: MEDVi prescribes compounded semaglutide (injection and tablet) and FDA-approved brand-name Wegovy® pill, Wegovy® injection, and Zepbound® injection. Found prescribes more than 10 medications including FDA-approved Wegovy®, Zepbound®, Saxenda®, Ozempic®, Mounjaro®, Foundayo™, plus compounded GLP-1 options and non-GLP-1 medications like metformin, contrave, topiramate, and zonisamide.
MEDVi’s medication menu
MEDVi is built around two product lines:
- Compounded GLP-1 medications — semaglutide injection or daily oral tablet. Compounded tirzepatide has also been offered historically — verify current availability at checkout. Compounded by U.S.-licensed pharmacies (Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding). Compounded medications are not FDA-approved.
- FDA-approved brand-name medications — recently added: Wegovy® pill, Wegovy® injection, and Zepbound® injection, on a $99 membership + medication-cost model. Availability subject to change.
Found’s medication menu
Found is built around a wider toolkit. Your clinician picks the right medication for your specific situation, including non-GLP-1 options if a GLP-1 isn’t right for you.
| Category | Medications |
|---|---|
| GLP-1 (FDA-approved for chronic weight management) | Wegovy® (semaglutide), Zepbound® (tirzepatide), Saxenda® (liraglutide), Foundayo™ (orforglipron, FDA-approved April 2026) |
| GLP-1 (FDA-approved for type 2 diabetes; may be prescribed off-label) | Ozempic®, Mounjaro®, Rybelsus®, Victoza®, Trulicity® |
| Compounded GLP-1 | Semaglutide, tirzepatide, liraglutide |
| Non-GLP-1 weight care | Metformin, contrave, topiramate, zonisamide |
| Specialty program | Microdose program for first-time GLP-1 users who want a slow start |
Compounded vs FDA-approved: the part most blogs blur
Compounded medications are not the same as FDA-approved medications. They are prepared by a licensed compounding pharmacy under a prescription. They contain medication ingredients, but the finished product has not been reviewed by the FDA for safety, effectiveness, or quality.
FDA-approved medications like Wegovy® and Zepbound® have gone through years of clinical trials and FDA review. The drug, the dose, the formulation, and the manufacturing are all reviewed.
In April 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list — a signal that the regulatory floor under compounded GLP-1 is rising. If you start on compounded medication, plan a transition path to FDA-approved brand-name for the long term.
If you specifically want FDA-approved medication and you have insurance, Found’s brand-name path is one option, and Ro is another we recommend for full insurance navigation →
Insurance — only one of these takes it
Answer capsule: Found says it accepts most major insurance plans for clinical care across 40+ states and offers a free coverage checker. MEDVi is cash-pay only — insurance is not billed directly. Both market HSA and FSA card acceptance, but final eligibility depends on your plan administrator.
Insurance is the single biggest decision split between MEDVi and Found.
How Found’s insurance works
Found has built insurance navigation into the front of the funnel. You start with a free coverage check: Found pulls your plan, contacts your insurer, and tells you what’s covered before you pay anything. If your insurance covers Wegovy® or another GLP-1, your branded medication cost can drop substantially below cash-pay rates.
Found’s pricing widget shows in-network plan availability across 40+ states, with major carrier logos including Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, and Anthem displayed. Coverage varies by plan and state — use Found’s coverage checker, not the homepage, to confirm your specific plan.
How MEDVi handles “insurance”
MEDVi doesn’t bill insurance. That’s it. The platform is cash-pay only.
- HSA and FSA cards accepted at checkout (eligibility per your plan administrator — keep your receipts)
- Reimbursement claims you file yourself for branded medications. Some plans will reimburse out-of-network purchases. Your plan administrator decides.
If you have insurance you want to use directly, MEDVi is not your platform. We’d send you to Found or to Ro for branded medication with full insurance navigation →
A note on HSA/FSA
Both providers market HSA and FSA card acceptance. Real-world reimbursement depends entirely on your plan administrator. Found’s own terms specifically caution that subscription fees are generally not covered by most insurance plans or third-party payment plans such as HSA or FSA. Save your receipts and verify with your plan.
Medicare and Medicaid
Per CMS, the Medicare GLP-1 Bridge program runs from July 1, 2026 to December 31, 2027 for eligible Medicare Part D beneficiaries, with prior authorization criteria. Eligible products include Foundayo™, Wegovy® injection and tablets, and Zepbound® KwikPen, with eligible beneficiaries paying a $50 copay. Medicaid GLP-1 coverage varies state-to-state. Neither MEDVi nor Found is set up to navigate Medicare or Medicaid directly.
If you’re on Medicare or Medicaid, take our matching quiz → for a routing answer instead of picking either of these platforms blind.
Is MEDVi or Found available in my state?
Answer capsule: Found’s pricing widget shows in-network insurance plans in 40+ states; California shows “No plans available for this state.” MEDVi publicly says it serves most U.S. states, with several states requiring a live consultation before prescription and a few states limiting which medication formulations can ship. Both providers should be verified in checkout — entering your state of residence on the signup flow is the only definitive answer.
How to verify state availability on Found:
- Go to Found’s pricing page (joinfound.com/plans-and-pricing)
- Use the state selector to see in-network plans
- If your state shows “No plans available,” confirm cash-pay availability on the signup flow
How to verify state availability on MEDVi:
- Start the MEDVi eligibility check (glp.medvi.org)
- Enter your state of residence
- Note any live-consult or formulation requirements before paying
Cancellation, refunds, and lock-in: read before you click checkout
Answer capsule: MEDVi is month-to-month with no contract on the compounded plan — cancel at least 72 hours before your billing date. MEDVi’s policy says there is no guarantee of results; refunds are generally not issued upon ordinary cancellation, but a full refund is given if a clinician medically disqualifies you. Found has a 3-day post-signup refund window (or before your first medical consultation, whichever comes first); after that, multi-month prepaid plans commit you to pay through the term.
This is the section most people skip and then complain about later. Don’t be that person.
MEDVi cancellation rules
- No contract. Month-to-month billing on the compounded plan.
- Cancel anytime by email or through the patient portal.
- Cancellation deadline: at least 72 hours before your next billing date.
- Refund after ordinary cancellation: generally not issued, per MEDVi’s policy.
- Medical-disqualification refund: full refund if a MEDVi-affiliated clinician determines you are not medically eligible for treatment.
- Results-based refunds: MEDVi markets a guarantee with a 5-month results-based program and a refund minus a 25% consultation fee. Read MEDVi’s current guarantee language at checkout before relying on it.
The MEDVi cancellation experience gets mixed reviews on Trustpilot and ConsumerAffairs. The pattern: people who emailed in time got cancelled cleanly. People who tried to cancel after the billing date were charged for that cycle. The 72-hour rule is the rule.
Found cancellation rules
- Monthly plans can be cancelled anytime, with at least 48 hours notice before renewal.
- Multi-month prepaid plans (Kickstart, 6-month, 12-month) — Found’s terms state that subscription fees are generally non-refundable. The lowest advertised prices are based on 12-month plans paid upfront.
- Early refund window: 3 days from original purchase OR before your first medical consultation, whichever comes first. Within that window, a full membership refund is available.
- Medications already shipped: generally non-refundable.
Side-by-side cancellation comparison
| Cancellation factor | MEDVi | Found |
|---|---|---|
| Contract / commitment | None on compounded plan | None on monthly plans; 3/6/12 months on prepaid plans |
| Cancel anytime? | Yes | Yes |
| Notice required | ≥72 hours before billing | ≥48 hours before renewal |
| Refund of recent payment? | Generally no, except medical disqualification | Yes, within 3 days of signup or before first consult |
| Medical disqualification refund? | Full refund | Membership refunded; medications already dispensed are not |
| Multi-month plan refund? | N/A on compounded | No — pay through full term |
Pre-checkout checklist (use this on either platform)
Before you click “pay” on either site, screenshot or write down:
If you can’t get a clear answer to any of those before you pay, don’t pay yet.
The damaging admission: MEDVi’s FDA warning letter, in context
Answer capsule: On February 20, 2026, the FDA issued warning letter #721455 to MEDVi alleging false or misleading claims and misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act, related to the compounded semaglutide and tirzepatide products marketed on the company’s website. The letter was part of an industry-wide enforcement wave that named more than 30 telehealth companies in the same period. The letter does not allege a specific patient injury or partner-pharmacy safety failure.
We’re putting this here, in the middle of the page, because it’s the single most important thing you should know about MEDVi before you sign up — and most affiliate pages either bury it or pretend it doesn’t exist.
What the letter alleges:
- MEDVi’s website featured pictured medication labels showing “MEDVi” on them, suggesting MEDVi was the actual compounder. MEDVi is not the compounder — partner pharmacies are.
- Marketing language on MEDVi’s site (including comparison claims to FDA-approved drugs) implied that the compounded products had been FDA-approved or evaluated when they had not been.
- Together, the FDA concluded the compounded products were “misbranded” under federal law and that delivering them into interstate commerce on this basis violated the Act.
What the letter does NOT allege:
- It does not allege a specific patient injury
- It does not allege a partner-pharmacy safety failure
- It does not allege fraud or harm
What’s true about warning letters generally. The FDA describes warning letters as informal, advisory communications that give companies a chance to address concerns before formal enforcement. That said, the letter to MEDVi specifically warns that failure to correct the cited violations may result in legal action, including seizure or injunction.
The broader context. MEDVi was not the only company warned. The FDA issued similar letters to 30+ telehealth companies in March 2026 about the same kind of marketing claims. This was an industry-wide enforcement wave. The broader regulatory environment for compounded GLP-1s is tightening — in April 2026, the FDA proposed excluding semaglutide and tirzepatide from the 503B bulks list.
What this means for you as a buyer. The medication you’d receive from MEDVi still comes from licensed U.S. compounding pharmacies under a prescription from a licensed provider. The way MEDVi described its product on the website is what the FDA challenged. If you start on compounded GLP-1, plan a transition path to FDA-approved brand-name medication for the long term.
The honest pivot: MEDVi does NOT have the cleanest regulatory record in the GLP-1 telehealth space. If avoiding regulatory headlines is your top priority, Found is the safer choice between these two — and Eden is another alternative if you still want compounded. But the warning letter addresses how MEDVi marketed its compounded products on its website, not patient injuries or partner-pharmacy operations.
If the warning letter is a dealbreaker for you, that’s a legitimate read of the facts. See our Eden review for an alternative compounded provider → or see our Ro comparison for FDA-approved branded medication with insurance navigation →
We’re not putting a CTA at the end of this section. You just learned something hard. Take your time and decide on your own terms.
Who should pick MEDVi?
Answer capsule: Pick MEDVi if you’re paying cash, want the simplest possible path to compounded semaglutide, value flexibility over commitment, and want medication included in one transparent monthly price. Don’t pick MEDVi first if you have insurance you want to use, want heavy coaching support, or consider the FDA warning letter a dealbreaker.
MEDVi is the right pick if you can say yes to most of these:
- • You’re paying cash. Insurance isn’t a factor.
- • You want the lowest possible first-month cost ($179).
- • You don’t want to be locked in. No contract on the compounded plan.
- • You want medication included. No separate billing surprises.
- • You want pharmacy transparency (partner pharmacies named publicly).
- • You’re comfortable with compounded medication after reading the FDA caveat above.
- • You want simple — not 10 medication tiers and a personalization quiz.
MEDVi is the wrong pick if any of these are true:
- • You have insurance and you want to use it.
- • You want FDA-approved brand-name Wegovy® or Zepbound® without paying full retail.
- • You want a coach, an app community, or non-GLP-1 medication options.
- • You consider MEDVi’s FDA warning letter a dealbreaker.
- • You want help navigating prior authorization with your insurer.
What MEDVi customers consistently say
Trustpilot (~4.4 stars, 12,700+ reviews)
“Fast approval,” “medication arrived quickly,” “support was responsive,” “providers listened to my questions.”
ConsumerAffairs (~3.4 stars, ~2,000+ reviews)
Billing complaints after missed cancellation window. Difficulty reaching customer service by phone. Refund disputes after cancellation timing.
Who should pick Found?
Answer capsule: Pick Found if you have insurance worth using, you want a coach plus an app community, you value a wider medication menu including non-GLP-1 options, or you’d otherwise pay full retail for brand-name Wegovy® or Zepbound®. Don’t pick Found if you want the simplest possible monthly cash-pay path or you don’t want the risk of a multi-month prepaid plan.
Found is the right pick if you can say yes to most of these:
- • You have insurance. Found’s whole reason for existing is making your insurance work for GLP-1 care.
- • You want coaching, an AI assistant, and an in-app member community — not just a prescription.
- • You want options beyond GLP-1 (metformin, contrave, topiramate, zonisamide).
- • You want FDA-approved brand-name medication and don’t want to overpay for it.
- • You’re willing to commit to a longer-term weight care relationship.
Found is the wrong pick if any of these are true:
- • You’re paying cash and want the simplest, lowest-friction monthly plan.
- • You’re not sure you’ll stick with the program more than 1–3 months.
- • You live in California (pricing widget shows “No plans available for this state”).
- • You want pharmacy transparency before checkout.
- • You’re on Medicare or Medicaid.
What Found customers consistently say
Trustpilot (~3.7 stars, ~680 reviews)
Named clinicians people loved, coaching that actually helped change habits, the community feature, sustained weight loss over a year-plus. Found’s homepage cites 12% average body weight loss in one year (1,773 users, self-reported). Individual results may vary.
BBB / ConsumerAffairs complaints
Being charged for months without medication delivery, cancellation requests taking weeks, the 3-day refund window being enforced even when no real consultation took place.
The 60-second decision tree
Answer capsule: Use these questions to find your right pick in under a minute. The first two answer most readers’ situation; the last four handle edge cases.
| If you answer YES to this… | Your better first step is… | Why |
|---|---|---|
| I’m paying cash | MEDVi | Cheapest first month, no contract, simplest billing |
| I want my insurance to cover this | Found | Only platform of these two that bills insurance |
| I want a coach, app, and community | Found | Found’s program is built around behavioral support |
| I want FDA-approved brand-name medication and I have insurance | Ro (alternative) | Strongest insurance navigation + branded formulary |
| I’m uncomfortable with MEDVi’s FDA warning letter | Eden (alternative) | Compounded option with cleaner regulatory record |
| I’m on Medicare or Medicaid | Take the quiz | Government insurance needs plan-specific routing |
| I’m not sure which fits me yet | Take the quiz | 60 seconds, gives you a personalized starting point |

What real customers think (with proper caveats)
Answer capsule: Both providers have thousands of reviews online. We pulled patterns from Trustpilot, ConsumerAffairs, and BBB to identify what users actually praise and complain about — not to prove medical results, but to flag friction you should know about before you pay.
MEDVi reviews — what users actually say
Trustpilot: ~4.4 stars across 12,700+ reviews at the time of verification. Trustpilot reviews skew toward invited customers who had a good experience.
ConsumerAffairs: ~3.4 stars across ~2,000+ reviews at the time of verification. ConsumerAffairs captures more complaint-driven sentiment.
Common positive comments (paraphrased): straightforward signup, fast medication delivery, providers who were responsive in the patient portal, clear pricing.
Common negative comments (paraphrased): billing surprises after the user thought they cancelled, difficulty reaching support by phone, frustration with refund timing.
Found reviews — what users actually say
Trustpilot (joinfound.com profile): ~3.7 stars across ~680 reviews at the time of verification.
Better Business Bureau: Multiple complaints about the 3-day refund window and confusion about whether a “consultation” had occurred when only intake forms were filled out.
Common positive comments (paraphrased): named clinicians people loved, coaching that actually helped change habits, the community feature, sustained weight loss over a year-plus.
Common negative comments (paraphrased): being charged for months that didn’t include medication delivery, cancellation requests taking weeks, the 3-day refund window being enforced even when no real consultation took place.
What FAQ readers actually ask
These are the most common questions people search around “MEDVi vs Found.” Each answer is a self-contained 2–3 sentence summary you can act on immediately.
Is MEDVi or Found cheaper?
MEDVi is cheaper for the first month at $179 and for cash-pay shoppers without insurance. Found is cheaper if your insurance covers your medication, or if you prepay 12 months upfront on the cash-pay plan ($199/mo vs MEDVi’s $299/mo ongoing).
Does Found accept insurance?
Yes. Found says it accepts most major insurance plans for clinical care across 40+ states and offers a free coverage checker that contacts your insurer. California shows “No plans available for this state” on the Found pricing widget. Coverage and copays vary by plan and state.
Does MEDVi accept insurance?
No. MEDVi is cash-pay only. You can use HSA or FSA cards subject to your plan administrator’s eligibility rules, and you may submit reimbursement claims to your insurance for branded medications, but MEDVi does not bill insurance directly.
What does Found cost per month?
Found’s GLP-1 program starts at $149/mo with insurance on a 12-month plan paid upfront, $199/mo cash-pay on a 12-month plan paid upfront, and $199–$299/mo on monthly plans. Brand-name medication is billed separately on top.
What does MEDVi cost per month?
MEDVi’s compounded semaglutide injections start at $179 the first month, then $299/mo. Tablets start at $249 the first month. Brand-name additions (Wegovy® pill, Wegovy® injection, Zepbound® injection) use a $99 membership + medication-cost model.
Did MEDVi get an FDA warning letter?
Yes. The FDA issued letter #721455 dated February 20, 2026, alleging false or misleading claims and misbranding related to compounded semaglutide and tirzepatide marketing and labeling. The letter was part of an industry-wide enforcement wave that named more than 30 telehealth companies in the same period.
Did Found get an FDA warning letter?
No FDA warning letter to Found Health, Inc. is in the FDA’s public warning letters database as of May 5, 2026.
Is the medication from MEDVi the same as Wegovy® or Ozempic®?
No. MEDVi’s compounded products are not Wegovy® or Ozempic®. FDA-approved Wegovy® and Ozempic® are made by Novo Nordisk and have undergone the FDA’s full new drug approval process. MEDVi’s compounded products are prepared by U.S.-licensed compounding pharmacies and have not been FDA-evaluated. MEDVi also offers brand-name Wegovy® and Zepbound® separately on its newer membership-plus-medication plans.
Are compounded GLP-1 medications FDA-approved?
No. Compounded medications are not FDA-approved. The FDA does not review compounded products for safety, effectiveness, or quality before they reach patients. Compounded medications can be legally prescribed when the conditions of federal compounding law (sections 503A and 503B) are met, and the FDA has stated that compounding should not be used to circumvent the FDA approval process.
Is Found’s medication FDA-approved?
It depends on what you’re prescribed. Found prescribes both FDA-approved brand-name GLP-1 medications and compounded options. Wegovy®, Zepbound®, Saxenda®, and Foundayo™ are FDA-approved for chronic weight management. Ozempic®, Mounjaro®, Rybelsus®, Victoza®, and Trulicity® are FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss at provider discretion. Compounded options are not FDA-approved.
Can I cancel MEDVi anytime?
Yes. MEDVi runs month-to-month with no contract on the compounded plan. Cancel by email at least 72 hours before your billing date. MEDVi’s official policy says refunds are generally not issued upon ordinary cancellation, with an exception for medical disqualification.
Can I cancel Found anytime?
Yes for monthly plans, with at least 48 hours notice before your renewal date. For multi-month prepaid plans (Kickstart, 6-month, 12-month), Found’s terms state that subscription fees are generally non-refundable — cancellation only stops auto-renewal at the end of the period.
Do MEDVi or Found work with HSA/FSA?
Both market HSA and FSA card acceptance. Final reimbursement depends on your plan administrator. Note: Found’s terms specifically caution that subscription fees are generally not covered by most insurance plans or third-party payment plans such as HSA/FSA — confirm with your benefits administrator before counting on reimbursement.
What happens if compounded GLP-1 becomes harder to access?
The regulatory environment for compounded GLP-1 is tightening. The FDA resolved the semaglutide and tirzepatide drug shortages in 2024–2025, and in April 2026 proposed excluding those medications from the 503B bulks list. Compounded medication remains legal today when prescribed for a specific patient need by a licensed clinician, but availability and the specific products allowed could narrow further in late 2026 or 2027. If you start on a compounded medication today, plan a transition path to FDA-approved brand-name medication for long-term use.
How we built this comparison (our methodology)
Answer capsule: We compared MEDVi and Found by reviewing each provider’s current pricing pages, terms of service, the FDA warning letters database, and third-party reviews on Trustpilot, ConsumerAffairs, and the Better Business Bureau on May 5, 2026. We did not place orders. We didn’t accept free or discounted product. We re-verify pricing and policy claims monthly.
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We earn affiliate commissions when readers sign up through our links — and we disclose that openly.
For this MEDVi vs Found page, our scoring weights:
| Factor | Weight | What we looked at |
|---|---|---|
| Price clarity | 20% | Can a normal person figure out what they’ll actually pay over 12 months? |
| Medication-route clarity | 20% | Is it clear which medications are compounded vs FDA-approved, and which FDA-approved medications are approved for weight loss vs prescribed off-label? |
| Insurance fit | 15% | Does the platform support insurance the way an actual insured user would need? |
| Cancellation/refund risk | 15% | How easy is it to leave if it’s not working? |
| Pharmacy/source transparency | 10% | Are partner pharmacies named publicly? |
| Regulatory caveats | 10% | Are FDA, state law, and compounding rules properly disclosed? |
| Support model | 5% | Is there a coach, an app, a community — or just a prescription? |
| User friction patterns | 5% | What do real users complain about after they pay? |
Where the evidence didn’t make one clear winner, we segmented by reader scenario rather than declaring a single “best” pick. That’s why this page recommends MEDVi for some readers and Found for others — because that’s what’s true.
The bottom line, one more time
- MEDVi is the right pick if you’re paying cash, you want the cheapest first month, you don’t want a contract, and you’ve read the FDA warning letter section above and made an informed call.
- Found is the right pick if you have insurance you want to use, you want a coach plus an app and community, you want FDA-approved brand-name medication at a meaningful discount, or you want non-GLP-1 medication options.
- If neither feels exactly right for your situation — Medicare/Medicaid, complex medical history, undecided on compounded vs branded, or first-time GLP-1 user who needs more guidance — don’t force a choice.
Still not sure? Take our free 60-second GLP-1 matching quiz →